Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

How should I treat critical stenosis of a saphenous venous graft to the posterior descending artery on the bifurcation site?

Russo F, De Nittis G, Zerboni SC, Valli P, Galli M, Abdou SM, Sachdeva R.

EuroIntervention. 2014;9(12):1478-82. doi: 10.4244/EIJV9I12A247. No abstract available.

2.

Non-ST-segment elevation myocardial infarction related to vulnerable neoatheroma in bare-metal stents 2 years after percutaneous coronary intervention of a coronary saphenous vein graft.

Roleder T, Wańha W, Smolka G, Ochała A, Wojakowski W.

JACC Cardiovasc Interv. 2014 Aug;7(8):e95-6. doi: 10.1016/j.jcin.2013.12.214. Epub 2014 Jul 30. No abstract available.

3.

Excimer laser for a highly stenotic saphenous vein graft: evidence of debulking by optical coherence tomography.

Niccoli G, Di Vito L, Montone RA, Porto I, Crea F.

EuroIntervention. 2014;9(12):1484. doi: 10.4244/EIJV9I12A249. No abstract available.

4.

"First-in-man" use of bioresorbable vascular scaffold in saphenous vein graft.

Ong PJ, Jafary FH, Ho HH.

EuroIntervention. 2013 May 20;9(1):165. doi: 10.4244/EIJV9I1A24. No abstract available.

5.

Follow-up results after interventional treatment of infarct-related saphenous vein graft occlusion.

Hoffmann R, Nitendo G, Deserno V, Adamu U, Almalla M, Blindt R, Vogt F.

Coron Artery Dis. 2010 Mar;21(2):61-4. doi: 10.1097/MCA.0b013e328332ee4b.

PMID:
20124993
6.

Comparison of long-term outcomes of drug-eluting stents and bare metal stents for saphenous vein graft stenosis.

Chakravarty T, Morrissey RP, Wertman B, Naghi J, Chou S, Goykhman P, Doctor N, Mirocha J, Forrester JS, Makkar R.

Catheter Cardiovasc Interv. 2012 May 1;79(6):903-9. doi: 10.1002/ccd.23187. Epub 2011 Jul 29.

PMID:
21805570
7.

Long-term comparison of everolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for percutaneous coronary intervention of saphenous vein grafts.

Taniwaki M, Räber L, Magro M, Kalesan B, Onuma Y, Stefanini GG, van Domburg RT, Moschovitis A, Meier B, Jüni P, Serruys PW, Windecker S.

EuroIntervention. 2014;9(12):1432-40. doi: 10.4244/EIJV9I12A241.

8.

Seven-year safety and efficacy of the unrestricted use of drug-eluting stents in saphenous vein bypass grafts.

Nauta ST, Van Mieghem NM, Magro M, Deckers JW, Simsek C, Van Geuns RJ, Van Der Giessen WJ, De Jaegere P, Regar E, Van Domburg RT, Serruys PW.

Catheter Cardiovasc Interv. 2012 May 1;79(6):912-8. doi: 10.1002/ccd.23145. Epub 2011 Nov 30.

PMID:
21542111
9.

In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry.

Tolerico PH, Cohen DJ, Kleiman NS, Berger PB, Brilakis ES, Piana RN, Shammo S, Keyes MJ, Kennedy KF, Massaro JM, Saucedo JF; EVENT Investigators.

Catheter Cardiovasc Interv. 2012 Dec 1;80(7):1127-36. doi: 10.1002/ccd.24352. Epub 2012 May 4.

PMID:
22431166
10.

Different vascular responses within the same stent detected by optical coherence tomography.

Samy B, Soeda T, Januzzi JL, Gaggin HK, Jang IK.

Coron Artery Dis. 2014 Aug;25(5):450-1. doi: 10.1097/MCA.0000000000000125. No abstract available.

PMID:
24842613
11.

Radial stent deformation in saphenous vein graft.

Sachdeva R, Aleti S, Thai H.

EuroIntervention. 2012 Nov 22;8(7):876-7. doi: 10.4244/EIJV8I7A131. No abstract available.

12.

Are our patients better off with drug-eluting stents in saphenous vein grafts?

Douglas JS Jr.

JACC Cardiovasc Interv. 2009 Nov;2(11):1113-5. doi: 10.1016/j.jcin.2009.09.007. No abstract available.

13.

Myocardial infarction in saphenous percutaneous intervention: are we really doing our best?

Lozano I, Rondan J, Avanzas P.

Am Heart J. 2009 Sep;158(3):e39; author reply e41. doi: 10.1016/j.ahj.2009.06.016. Epub 2009 Jul 22. No abstract available.

PMID:
19699850
14.

Angiographic and clinical results of everolimus-eluting stent utilization in saphenous vein graft lesions (ARES).

Jim MH, Wong KL, Yiu KH.

Int J Cardiol. 2015 Apr 1;184:433-5. doi: 10.1016/j.ijcard.2015.03.030. Epub 2015 Mar 4. No abstract available.

PMID:
25755061
15.

A unique stenosis in saphenous vein graft visualized by optical coherence tomography.

Koeda Y, Itoh T, Fusazaki T, Nakamura M, Morino Y.

Heart Vessels. 2014 Mar;29(2):278-81. doi: 10.1007/s00380-013-0362-x. Epub 2013 May 28.

16.

Complex vein graft intervention after double-valve transcatheter aortic valve replacement.

D'Amario D, Vergallo R, Trani C, Crea F, Porto I.

Coron Artery Dis. 2017 Mar;28(2):173-174. doi: 10.1097/MCA.0000000000000413. No abstract available.

PMID:
27501405
17.

Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: insights from the SOS (stenting of saphenous vein grafts) trial.

Lichtenwalter C, de Lemos JA, Roesle M, Obel O, Holper EM, Haagen D, Saeed B, Iturbe JM, Shunk K, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger P, Banerjee S, Brilakis ES.

JACC Cardiovasc Interv. 2009 Sep;2(9):855-60. doi: 10.1016/j.jcin.2009.06.014.

18.

Double jeopardy, double trouble.

Blankenship JC.

Catheter Cardiovasc Interv. 2010 Aug 1;76(2):279-80. doi: 10.1002/ccd.22709. No abstract available.

PMID:
20665877
19.

Long-term follow-up of lesion-specific outcomes comparing drug-eluting stents and bare metal stents in diseased saphenous vein grafts.

Runyan D, Gorges R, Feldman D, McCullough PA, David S, Saba S.

Rev Cardiovasc Med. 2013;14(1):1-6.

PMID:
23651982
20.

DES in SVGs: safe and at least short-term effective.

Hillegass WB.

Catheter Cardiovasc Interv. 2011 Feb 15;77(3):356-7. doi: 10.1002/ccd.22972. No abstract available.

PMID:
21328680

Supplemental Content

Support Center